Copyright
©The Author(s) 2003.
World J Gastroenterol. Oct 15, 2003; 9(10): 2154-2159
Published online Oct 15, 2003. doi: 10.3748/wjg.v9.i10.2154
Published online Oct 15, 2003. doi: 10.3748/wjg.v9.i10.2154
Table 3 Intensity of Ets1 staining in stromal cell and distri-bution of patients
| Compartment | No. | Weak (+) | Moderate (++) | Intense (≥ +++) | P value |
| Stromal cells | 40 | 3 (7.5%) | 21 (52.5%) | 16 (40%) | |
| T classification | |||||
| T1, 2 | 15 | 3 (20%) | 7 (46.7%) | 5 (33.3%) | 0.066 |
| T3, 4 | 25 | 0 (0%) | 14 (56%) | 11 (44%) | |
| LN metastasis* | |||||
| Negative | 14 | 3 (21.4%) | 6 (42.9%) | 5 (35.7%) | 0.048 |
| Positive | 26 | 0 (0%) | 15 (57.7%) | 11 (42.3%) | |
| Distant metastasis | |||||
| Negative | 39 | 3 (7.7%) | 21 (53.8%) | 15 (38.5%) | 0.463 |
| Positive | 1 | 0 (0%) | 0 (0%) | 1 (100%) | |
| Clinical stage | |||||
| Stage I, II | 18 | 3 (16.7%) | 8 (44.4%) | 7 (38.9%) | 0.129 |
| Stage III, IV | 22 | 0 (0%) | 13 (59.1%) | 9 (40.9%) | |
- Citation: Yu Y, Zhang YC, Zhang WZ, Shen LS, Hertzog P, Wilson TJ, Xu DK. Ets1 as a marker of malignant potential in gastric carcinoma. World J Gastroenterol 2003; 9(10): 2154-2159
- URL: https://www.wjgnet.com/1007-9327/full/v9/i10/2154.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i10.2154